Core Viewpoint - Huakang Clean (301235.SZ) has won the bid for the procurement project of special departments for the People's Hospital of Donglin New District, Fuzhou, with a confirmed bid amount of 50,070,669.35 yuan [1] Group 1 - The company participated in the bidding for the procurement project organized by the Public Service Bureau of Donglin New District [1] - The bid result was officially announced on September 10, 2025, by the Jiangxi Provincial Public Resources Trading Platform [1] - The confirmed bid amount is approximately 50 million yuan [1]

Core Viewpoint - Huakang Clean (301235.SZ) has won a bid for the procurement project of special departments at Fuzhou East New District People's Hospital, with a contract amount of 50.07 million yuan, representing 2.93% of the company's audited revenue for the fiscal year 2024 [1] Group 1 - The company participated in the bidding for the procurement project organized by the Fuzhou East New District Public Service Bureau [1] - The bid results were announced on September 10, 2025, confirming the company as the successful supplier [1] - The contract amount of 50.07 million yuan is significant for the company's financials, accounting for 2.93% of its projected revenue for 2024 [1]

证券代码：301235 证券简称：华康洁净 公告编号：2025-109 转债代码：123251 转债简称：华医转债 武汉华康世纪洁净科技股份有限公司 关于项目中标及收到中标通知书的公告 | 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 | | --- | | 载、误导性陈述或重大遗漏。 | 二、交易对手方情况 1、采购人名称：抚州市东临新区公共服务局 2、采购代理机构名称：江西诚科建设咨询监理有限公司 3、中标项目名称：抚州市东临新区人民医院特殊科室采购项目 4、供应商名称：武汉华康世纪洁净科技股份有限公司 5、中标（成交）金额：50,070,669.35 元 6、公示媒体：江西省公共资源交易平台（https://ggzy.jiangxi.gov.cn） 1、机构名称：抚州市东临新区公共服务局 2、负责人：林丽华 3、注册地址：抚州市东临新区管委会行政服务中心 4、公司、控股股东及实际控制人与交易对手方之间不存在关联关系，最近 三年未与交易对手方发生类似交易情况。 5、履约能力分析：本项目建设资金来源于财政资金。交易对手方资信情况 良好，不存在履约能力、信用状况及支付能力等方面的风险。 ...

Company Overview - Wuhan Huakang Century Clean Technology Co., Ltd. is located in Wuhan, Hubei Province, and was established on November 12, 2008. The company went public on January 28, 2022. Its main business involves the research, design, implementation, and operation of medical purification systems, as well as the sale of related medical equipment and consumables [1][2]. Financial Performance - For the first half of 2025, the company achieved operating revenue of 835 million yuan, representing a year-on-year growth of 50.73%. The net profit attributable to the parent company was 18.68 million yuan, showing a significant increase of 273.48% compared to the previous year [2]. - Since its A-share listing, the company has distributed a total of 40.02 million yuan in dividends, with 29.46 million yuan distributed over the past three years [3]. Stock Performance - As of September 10, the stock price of Huakang Clean increased by 2.05%, reaching 32.32 yuan per share, with a total market capitalization of 3.483 billion yuan. The stock has risen by 60.31% year-to-date, although it has seen a decline of 3.84% over the past five trading days [1]. - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent appearance on July 31 [1]. Shareholder Information - As of August 29, the number of shareholders for Huakang Clean was 11,200, an increase of 3.20% from the previous period. The average number of circulating shares per person decreased by 3.10% to 6,465 shares [2]. - Notable institutional shareholders include Anxin Medical Health Stock A, which is the fifth-largest shareholder with 652,800 shares, and Nuoan Multi-Strategy Mixed A, which is the tenth-largest shareholder with 429,900 shares, both of which are new entrants [3]. Business Segmentation - The company's revenue composition is as follows: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1]. Industry Classification - Huakang Clean is classified under the pharmaceutical and biological industry, specifically in the medical device sector. It is associated with concepts such as artificial intelligence, smart healthcare, margin financing, specialized and innovative enterprises, and QFII holdings [2].

Core Viewpoint - Huakang Clean experienced a decline of 4.14% on August 27, with a trading volume of 132 million yuan, indicating potential volatility in its stock performance [1]. Financing Summary - On August 27, Huakang Clean had a financing buy-in amount of 11.25 million yuan, with a net financing purchase of 3.01 million yuan after repayments [1]. - The total financing and securities balance reached 60.12 million yuan, accounting for 1.73% of the circulating market value, which is above the 90th percentile level over the past year, indicating a high financing level [1]. - The company had no short selling activity on August 27, with a short selling balance of 0, also reflecting a high percentile level over the past year [1]. Business Performance - As of August 20, Huakang Clean reported 10,900 shareholders, a decrease of 27.60%, while the average circulating shares per person increased by 38.12% to 6,672 shares [2]. - For the first half of 2025, Huakang Clean achieved a revenue of 835 million yuan, representing a year-on-year growth of 50.73%, and a net profit attributable to shareholders of 18.68 million yuan, up 273.48% year-on-year [2]. Dividend Information - Since its A-share listing, Huakang Clean has distributed a total of 40.02 million yuan in dividends, with 29.46 million yuan distributed over the past three years [3]. Shareholder Composition - As of June 30, 2025, among the top ten circulating shareholders, Anxin Medical Health Stock A is the fifth largest with 652,800 shares, marking it as a new shareholder [3]. - Nuoan Multi-Strategy Mixed A ranks as the tenth largest circulating shareholder with 429,900 shares, also a new addition [3].

Group 1 - The core point of the news is that Sunshine Life Insurance Co., Ltd. plans to reduce its stake in Huakang Clean (301235.SZ) by up to 3,233,017 shares, which represents a maximum of 3% of the company's total share capital [1] - Sunshine Life holds 5,605,246 shares, accounting for 5.2013% of the total share capital, and 5.3709% when excluding shares in the company's repurchase account [1] - The reduction will not lead to a change in control of the company and will not significantly impact its equity structure, governance, or ongoing operations [1] Group 2 - Huakang Clean raised a total of 1.03752 billion yuan during its IPO, with a net amount of 949.5028 million yuan after deducting issuance costs [2] - The actual net fundraising amount exceeded the original plan by 545.0644 million yuan, which was initially set at 404.4384 million yuan for various projects [2] - The total issuance costs amounted to 88.0172 million yuan, including underwriting and sponsorship fees of 68.6709 million yuan [2] Group 3 - The company has received approval from the China Securities Regulatory Commission to issue 7.5 million convertible bonds, with a total fundraising amount of 750 million yuan [3] - After deducting various issuance costs, the actual net amount raised from the bond issuance was approximately 743.8169 million yuan [3] - The funds from the bond issuance were confirmed to have been received on December 27, 2024, and were verified by an accounting firm [3] Group 4 - The total amount raised by Huakang Clean from two fundraising events is 1.788 billion yuan [4]

经济观察网华康洁净（301235）(301235.SZ)9月7日公告，公司股东阳光（600673）人寿保险股份有限 公司(简称"阳光人寿")拟通过集中竞价、大宗交易的方式减持不超过323.3万股，拟减持比例不超过公司 总股本的3.0000%。 ...

Core Viewpoint - Sunshine Life Insurance Co., Ltd. plans to reduce its stake in Huakang Clean (301235) by up to 3% of the total share capital, amounting to a maximum of 3.233 million shares within three months after 15 trading days [1] Summary by Relevant Sections - Shareholder Information - Sunshine Life holds 5.20% of Huakang Clean's shares [1] - Reduction Plan - The reduction will be executed through centralized bidding and block trading methods [1] - The maximum number of shares to be reduced is 3.233 million [1] - The reduction period is set for three months following a 15 trading day notice period [1]

智通财经APP讯，华康洁净(301235.SZ)公告，公司股东阳光人寿保险股份有限公司(简称"阳光人寿")拟 通过集中竞价、大宗交易的方式减持不超过323.3万股，拟减持比例不超过公司总股本的3.0000%。 ...

Core Viewpoint - Sunshine Life Insurance Co., Ltd. plans to reduce its holdings in Wuhan Huakang Century Clean Technology Co., Ltd. by up to 3,233,017 shares, representing a maximum of 3% of the company's total share capital, within three months after the announcement [1][2]. Group 1: Shareholder Information - Sunshine Life holds 5,605,246 shares of the company, accounting for 5.2013% of the total share capital as of September 4, 2025 [1][2]. - The shares held by Sunshine Life are all unrestricted tradable shares [1]. Group 2: Reduction Plan Details - The reduction plan allows for a maximum of 3% of the total share capital to be sold, with adjustments made if the total share capital changes due to various corporate actions [2][3]. - The plan includes a stipulation that if the company undergoes actions such as stock dividends or capital increases, the number of shares to be reduced will remain unchanged, but the percentage will be adjusted accordingly [2][3]. Group 3: Shareholder Commitments - Sunshine Life has committed not to transfer or manage its shares for 12 months following the company's stock listing [3]. - Any profits from unauthorized share reductions will belong to the company, and Sunshine Life must comply with relevant regulations regarding share reductions [3][4]. Group 4: Compliance and Impact - The reduction plan is consistent with previous commitments made by Sunshine Life, and there have been no violations of these commitments to date [4][5]. - The implementation of this reduction plan will not lead to a change in control of the company or significantly impact its equity structure or ongoing operations [5].